The latest product in Febit's Geniom family, the Geniom RT analyser enables the fully automated processing of microarrays on Febit's own Geniom biochips
Febit will introduce the Geniom RT analyser to the US market at RNAi World Congress, which will take place 30 April - 2 May 2008 in Boston.
RNA-researchers, one of the main user groups of Febit's new device, will benefit from the microarray technology device's high degree of automation and flexibility.
In addition, microRNA researchers will enjoy febit's recently released microarray based on Sanger miRBase-Version 11.0.
The compact all-in-one device, which employs microfluidics, provides users with high sample throughput, excellent reproducibility, high sensitivity and a variety of applications.
In addition, the product's freely programmable and precise temperature control optimises hybridisations and enables the use of enzymatic reactions directly on the microfluidic array for signal enhancement and primer extension assays.
"We have brought together in one benchtop tool the automation of multiple processes involved with the identification and understanding of how genes work," said Cord Staehler, president and CEO of Febit.
"This is all about flexibility, control of experiments and time savings.
"Still, we provide more than a machine with the Geniom RT analyser.
"Our approach is an important combination of tools and talent to help researchers meet their needs.
"With the demand we're seeing for the Geniom RT analyser, we're expanding our US sales and support team as well as moving our lab and training center to a larger facility in the Boston area".
Based on the proven Geniom technology, Febit offers microarray analytics for a broad spectrum of DNA and RNA samples.
The array design can be chosen from current databases or freely configured by the user.
Geniom arrays are produced on demand at febit and subject to rigorous quality control before shipment to the customer.
Alternatively, researchers may prefer the Geniom One System, which enables integrated microarray synthesis in the user's own laboratory.
This provides an independent workflow with complete control of the microarray experiments.
For utmost flexibility and maximis ed throughput, both instruments can be utilised in combination.
